Related Experiment Video
Updated: Jun 23, 2026
Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
Beneficial effects of intravenous nitroglycerin on haemodynamics and enzymatically estimated infarct size
Insights
Intravenous nitroglycerin (TNG) significantly reduced infarct size in acute myocardial infarction patients. Early TNG administration, especially in those with left ventricular failure, yielded the best outcomes for reducing heart attack damage.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute myocardial infarction (AMI) is a leading cause of mortality worldwide.
- Left ventricular failure complicates AMI, increasing morbidity and mortality.
- Effective early management strategies for AMI are crucial.
Purpose of the Study:
- To evaluate the effects of intravenous nitroglycerin (TNG) on infarct size and hemodynamic parameters in patients with first acute myocardial infarction.
- To assess whether TNG efficacy differs based on the presence of left ventricular failure (Killip classes II and III).
Main Methods:
- A randomized controlled trial involving 39 patients with first AMI treated with intravenous TNG.
- Patients were subgrouped based on Killip classification (with or without left ventricular failure).
- A control group (N=38) received conventional treatment.
Main Results:
- TNG significantly reduced pulmonary artery diastolic pressure by approximately 30% in all patients.
- TNG treatment resulted in a ~40% reduction in infarct size (measured by CK-MB) in both patient subgroups compared to controls.
- Peak CK-MB levels were significantly lower in the TNG group with left ventricular failure.
Conclusions:
- Intravenous nitroglycerin is effective in reducing infarct size in acute myocardial infarction.
- Early administration of TNG (within 4 hours of symptom onset) appears most beneficial.
- TNG may offer particular benefits in patients experiencing left ventricular failure during AMI.
Abstract:
The effects of intravenous nitroglycerin (TNG) were evaluated in 39 patients with a first acute myocardial infarction, subdivided according to Killip into those with left ventricular failure (N = 24) and those without (N = 15). A group of 38 randomly selected patients treated in a conventional, but unstandardized manner, served as a control (C). TNG caused a statistically significant reduction in pulmonary artery diastolic pressure, regardless of its initial value, by about 30%. Neither cardiac index nor total peripheral resistance was significantly changed. Infarct size, measured in gEq of isoenzyme MB creatine kinase (CK-MB), was smaller by about 40% in both subgroups of patients treated with TNG, when compared with the controls. A significant difference was found in peak CK-MB blood levels only in the group of patients with left ventricular failure (Killip classes II and III) treated with TNG. The best results were obtained when TNG was given not later than 4 h after the onset of the symptoms of infarction.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management
01:20Angina V: Nursing Management